These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11408289)

  • 21. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B; Jack C; Ramjee G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost of antiretroviral drugs and influence on prescribing policies.
    Jones R; Gazzard B
    Int J STD AIDS; 2006 Aug; 17(8):499-506. PubMed ID: 16925892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral therapy in South Africa--can we do it?
    Bekker LG; Wood R
    S Afr Med J; 2002 Mar; 92(3):191-3. PubMed ID: 12040936
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. South Africa begins implementing ambitious HIV program. Government-funded initiative faces great challenges on several fronts.
    AIDS Alert; 2004 Aug; 19(8):suppl 1-2. PubMed ID: 15300949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HAART--the need for strategically focused investments.
    Feachem R
    Bull World Health Organ; 2001; 79(12):1152-3. PubMed ID: 11842786
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow.
    Fox R; Gourlay YJ
    Health Bull (Edinb); 2000 Jul; 58(4):309-15. PubMed ID: 12813810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
    Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
    Flanigan TP; Wools-Kaloustain K; Harwell J; Cu-Uvin S; Kimaiyo S; Carter EJ
    Clin Infect Dis; 2007 Dec; 45(11):1499-501. PubMed ID: 17990234
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS is your business.
    Rosen S; Simon J; Vincent JR; MacLeod W; Fox M; Thea DM
    Harv Bus Rev; 2003 Feb; 81(2):80-7, 125. PubMed ID: 12577655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa.
    Schuelter-Trevisol F; Trevisol DJ; Fuchs SC
    AIDS; 2009 Apr; 23(7):871-2; author reply 872-3. PubMed ID: 19363333
    [No Abstract]   [Full Text] [Related]  

  • 35. Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women.
    Currier JS
    Clin Infect Dis; 2007 Jul; 45(2):261-2. PubMed ID: 17578789
    [No Abstract]   [Full Text] [Related]  

  • 36. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral therapy: a key part of the public health response to injection drug use.
    Wood E; Montaner JS
    Addiction; 2008 Apr; 103(4):660-1. PubMed ID: 18339111
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiretroviral drug development: the challenge of cost and access.
    Dunne M
    AIDS; 2007 Jul; 21 Suppl 4():S73-9. PubMed ID: 17620756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges to pediatric HIV care and treatment in South Africa.
    Meyers T; Moultrie H; Naidoo K; Cotton M; Eley B; Sherman G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S474-81. PubMed ID: 18181697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutting the cost of South African antiretroviral therapy using newer, safer drugs.
    Venter WF; Kaiser B; Pillay Y; Conradie F; Gomez GB; Clayden P; Matsolo M; Amole C; Rutter L; Abdullah F; Abrams EJ; Casas CP; Barnhart M; Pillay A; Pozniak A; Hill A; Fairlie L; Boffito M; Moorhouse M; Chersich M; Serenata C; Quevedo J; Loots G
    S Afr Med J; 2016 Dec; 107(1):28-30. PubMed ID: 28112085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.